{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:03:17Z","timestamp":1775714597620,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.antiviral.2008.01.007","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T14:23:50Z","timestamp":1202999030000},"page":"230-241","source":"Crossref","is-referenced-by-count":52,"title":["C3H\/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection"],"prefix":"10.1016","volume":"78","author":[{"given":"Justin G.","family":"Julander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Skirpstunas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatraman","family":"Siddharthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin D.","family":"Hoopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald F.","family":"Smee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Morrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.007_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00126839-200405050-00006","article-title":"Mismatched double-stranded RNA: polyI:polyC12U","volume":"5","author":"Anon.","year":"2004","journal-title":"Drugs R D"},{"key":"10.1016\/j.antiviral.2008.01.007_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/viro.2000.0241","article-title":"A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus","volume":"270","author":"Aronson","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.007_bib3","first-page":"209","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells","volume":"73","author":"Berge","year":"1961","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2008.01.007_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/viro.2001.0878","article-title":"Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse","volume":"284","author":"Charles","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.007_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1006\/viro.1995.1197","article-title":"Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse","volume":"208","author":"Charles","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.007_bib6","first-page":"99","article-title":"A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis","volume":"9","author":"Davis","year":"1994","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.antiviral.2008.01.007_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4269\/ajtmh.1985.34.194","article-title":"The systemic pathology of Venezuelan equine encephalitis virus infection in humans","volume":"34","author":"de la Monte","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2008.01.007_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/110.1.80","article-title":"The comparative pathology of experimental Venezuelan equine encephalomyelitis infection in different animal hosts","volume":"110","author":"Gleiser","year":"1962","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.007_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1997.8617","article-title":"Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus","volume":"233","author":"Grieder","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.007_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1006\/viro.1995.1022","article-title":"Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins","volume":"206","author":"Grieder","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.007_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.1997.tb01013.x","article-title":"The role of antibody in recovery from alphavirus encephalitis","volume":"159","author":"Griffin","year":"1997","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2008.01.007_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0264-410X(96)00204-6","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB\/c, but not C3H\/HeN mice","volume":"15","author":"Hart","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2008.01.007_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/030098589102800509","article-title":"Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters","volume":"28","author":"Jackson","year":"1991","journal-title":"Vet. Pathol."},{"issue":"Pt 9","key":"10.1016\/j.antiviral.2008.01.007_bib14","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1099\/0022-1317-67-9-1951","article-title":"Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus","volume":"67","author":"Johnson","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/IAI.7.6.911-917.1973","article-title":"Interferon sensitivity of Venezuelan equine encephalomyelitis virus","volume":"7","author":"Jordan","year":"1973","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2008.01.007_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.virol.2006.10.031","article-title":"Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model","volume":"360","author":"Julander","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.007_bib17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/JVI.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1128\/AAC.11.4.683","article-title":"Indirect mouse model for the evaluation of potential antiviral compounds: results with Venezuelan equine encephalomyelitis virus","volume":"11","author":"Kuehne","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.007_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/AAC.47.2.777-782.2003","article-title":"Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice","volume":"47","author":"Leyssen","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.007_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2008.01.007_bib21","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1128\/JVI.74.11.5006-5015.2000","article-title":"Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection","volume":"74","author":"Lukaszewski","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1743-422X-3-19","article-title":"Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques","volume":"3","author":"Muehlenbein","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2008.01.007_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0166-3542(93)90051-J","article-title":"The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus","volume":"21","author":"Niu","year":"1993","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.007_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0192-0561(88)90050-1","article-title":"Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses","volume":"10","author":"Pinto","year":"1988","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib25","first-page":"493","article-title":"A simple method of estimating fifty percent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2008.01.007_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(00)00290-3","article-title":"Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice","volume":"109","author":"Schoneboom","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-3542(93)90059-R","article-title":"Treatment of lethal Pichinde virus infections in weanling LVG\/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen","volume":"20","author":"Smee","year":"1993","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.007_bib28","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1128\/JVI.72.12.10286-10291.1998","article-title":"Resistance to alpha\/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5\u2032 noncoding region and glycoproteins","volume":"72","author":"Spotts","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4049\/jimmunol.152.3.1289","article-title":"Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response","volume":"152","author":"Wesselingh","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.007_bib32","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/JVI.75.8.3706-3718.2001","article-title":"Role of alpha\/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5\u2032 untranslated region","volume":"75","author":"White","year":"2001","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T13:57:47Z","timestamp":1684245467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0166354208000260"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}